title: Oxidation Protection in Metal-Binding Peptide Motif and Its Application to Antibody for Site-Selective Conjugation.
abstract: Here, we demonstrate that a metal ion binding motif could serve as an efficient and robust tool for site-specific conjugation strategy. Cysteine-containing metal binding motifs were constructed as single repeat or tandem repeat peptides and their metal binding characteristics were investigated. The tandem repeats of the Cysteine-Glycine-Histidine (CGH) metal ion binding motif exhibited concerted binding to Co(II) ions, suggesting that conformational transition of peptide was triggered by the sequential metal ion binding. Evaluation of the free thiol content after reduction by reducing reagent showed that metal-ion binding elicited strong retardation of cysteine oxidation in the order of Zn(II)>Ni(II)>Co(II). The CGH metal ion binding motif was then introduced to the C-terminus of antibody heavy chain and the metal ion-dependent characteristics of oxidation kinetics were investigated. As in the case of peptides, CGH-motif-introduced antibody exhibited strong dependence on metal ion binding to protect against oxidation. Zn(II)-saturated antibody with tandem repeat of CGH motif retains the cysteine reactivity as long as 22 hour even with saturating O2 condition. Metal-ion dependent fluorophore labeling clearly indicated that metal binding motifs could be employed as an efficient tool for site-specific conjugation. Whereas Trastuzumab without a metal ion binding site exhibited site-nonspecific dye conjugation, Zn(II) ion binding to antibody with a tandem repeat of CGH motif showed that fluorophores were site-specifically conjugated to the heavy chain of antibody. We believe that this strong metal ion dependence on oxidation protection and the resulting site-selective conjugation could be exploited further to develop a highly site-specific conjugation strategy for proteins that contain multiple intrinsic cysteine residues, including monoclonal antibodies.
authors.affiliation: Department of Biological Sciences and Biotechnology, College of Life Science and Nano Technology, Hannam University, 1646, Yuseong-daero, Yuseong-gu, Daejeon, Korea.|Alteogen Inc., Yuseong-daero 62, Jeon-min Dong, Yuseong-gu, Daejeon, Korea.
authors.forename: Hye-Shin
authors.initials: HS
authors.lastname: Chung
authors.affiliation: Alteogen Inc., Yuseong-daero 62, Jeon-min Dong, Yuseong-gu, Daejeon, Korea.
authors.forename: Sunbae
authors.initials: S
authors.lastname: Lee
authors.affiliation: Alteogen Inc., Yuseong-daero 62, Jeon-min Dong, Yuseong-gu, Daejeon, Korea.
authors.forename: Soon Jae
authors.initials: SJ
authors.lastname: Park
mesh_terms: D000478:Alkylation; D020816:Amino Acid Motifs; D000818:Animals; D001665:Binding Sites; D016466:CHO Cells; D003035:Cobalt / Q000378:metabolism*; D003412:Cricetulus; D006801:Humans; D018796:Immunoconjugates / Q000737:chemistry / Q000378:metabolism*; D009532:Nickel / Q000378:metabolism*; D010084:Oxidation-Reduction; D010455:Peptides / Q000737:chemistry / Q000378:metabolism*; D000068878:Trastuzumab / Q000737:chemistry / Q000378:metabolism*; D015032:Zinc / Q000378:metabolism*
chemical_list: D018796:Immunoconjugates; D010455:Peptides; D003035:Cobalt; D009532:Nickel; D015032:Zinc; D000068878:Trastuzumab